22Mar
HHS Declares Liability Immunity for Certain COVID-19 “Countermeasures”; Response Act Expands Protections for Mask Makers
Earlier this week, we discussed current trends and future implications of COVID-19 on businesses operating in the products arena, noting the most direct impact so far on the pharmaceutical and medical device spaces. Recognizing the potential...
By:
Butler Snow LLP
Related
In Tuesday's Report: the expanding role of real-world evidence in FDA medical device submissions; Pr...
Read More >
In products liability litigation, the question of whether a product was defectively designed because...
Read More >
The SECURE Act* (the “Act”) makes significant changes to employer-sponsored retirement plans, and ...
Read More >
Seyfarth Synopsis: It should be clear to all that the NLRB has taken significant steps to restore th...
Read More >
Employers often debate whether to use E-Verify—a free, mostly voluntary Web-based tool that allows ...
Read More >
Many employers offer employees the option to use the employer’s cafeteria plan to opt-out of group ...
Read More >